Healthcare Sep 21, 2022 10:38 AM (GMT+8) · EqualOcean
Suzhou Weiyou Gene Biotechnology (Chinese: 苏州惟佑基因生物科技有限公司) recently completed a pre-A round of financing worth tens of millions of CNY, which was led by Proxima ventures (Chinese: 比邻星创投) exclusively. Suzhou Weiyou Gene Biotechnology is a gene therapy platform company built through gene therapy technology founded in 2021. The company's team has rich R&D experience and muscular strength and has the world's leading industrialization experience. The company has established a rich drug research and development pipeline. Its indications cover ophthalmology, dermatology, blood and central nervous system diseases.